Cutler Group LLC / CA - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$3,000
+50.0%
7,8400.0%0.00%
Q3 2016$2,0000.0%7,8400.0%0.00%
Q2 2016$2,000
-50.0%
7,8400.0%0.00%
Q1 2016$4,000
-66.7%
7,840
-56.1%
0.00%
-100.0%
Q4 2015$12,00017,8400.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 44,796,940$18,053,0003.63%
Stonepine Capital Management, LLC 2,617,136$1,067,0000.64%
FIRST NEW YORK SECURITIES LLC /NY 35,000$14,266,0000.03%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 526,210$2,157,0000.02%
Caprock Group, LLC 150,000$61,0000.02%
TIEDEMANN ADVISORS, LLC 334,310$136,0000.01%
JW Asset Management, LLC 50,254$21,0000.01%
Nine Chapters Capital Management LLC 17,200$7,0000.01%
TWO SIGMA SECURITIES, LLC 60,419$24,0000.01%
WASHINGTON TRUST Co 314,000$128,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders